Immunic (IMUX) Goodwill (2019 - 2022)

Immunic (IMUX) has 4 years of Goodwill data on file, last reported at $33.0 million in Q3 2022.

• For the quarter ending Q3 2022, Goodwill changed 0.0% year-over-year to $33.0 million; the trailing twelve-month figure through Sep 2022 stood at $33.0 million (changed 0.0% YoY), and the FY2021 full-year result was $33.0 million, changed 0.0% from the prior year.
• Goodwill was little changed at $33.0 million in Q3 2022, from $33.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $33.0 million in Q2 2019 to a low of $33.0 million in Q2 2019.
• A 4-year average of $33.0 million and a median of $33.0 million in 2019 frame the typical range for Goodwill.
• Peak annual rise in Goodwill reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
• Tracing IMUX's Goodwill over 4 years: stood at $33.0 million in 2019, then changed by 0.0% to $33.0 million in 2020, then changed by 0.0% to $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022.
• Business Quant data shows IMUX's Goodwill at $33.0 million in Q3 2022, $33.0 million in Q2 2022, and $33.0 million in Q1 2022.